What is the Difference Between PCNA and Ki67?
🆚 Go to Comparative Table 🆚PCNA and Ki67 are both cell proliferation markers used in the diagnosis and prognosis of various cancers. However, there are differences between the two:
- Function: PCNA is a nuclear protein involved in DNA synthesis and repair pathways, while Ki67 is a nuclear protein involved in cell proliferation and ribosomal RNA transcription.
- Proliferation phases: PCNA is mainly involved in late G1 and S phases, while Ki67 is involved in G1, S, G2, and M phases.
- Sensitivity and specificity: Multiple studies have shown that Ki67 is more sensitive and specific when evaluating cell proliferation in tumors from various origins.
- Immunohistochemistry detection: Both PCNA and Ki67 can be detected through immunohistochemistry techniques.
In summary, PCNA and Ki67 are both used as cell proliferation markers, but they have different functions and levels of sensitivity and specificity. Ki67 is generally considered to be more specific and sensitive for evaluating cell proliferation in tumors, making it a more popular choice in cancer diagnosis and prognosis.
Comparative Table: PCNA vs Ki67
PCNA and Ki67 are both nuclear proteins associated with cell proliferation, but they have distinct roles and subcellular localization. Here is a table summarizing their differences:
Feature | PCNA (Proliferating Cell Nuclear Antigen) | Ki67 (Proliferation-Associated Nuclear Antigen) |
---|---|---|
Function | Involved in DNA synthesis and repair pathways | Involved in cell proliferation and ribosomal RNA transcription |
Subcellular Localization | Present in the G1 and S phases of the cell cycle | Recognizes nuclear antigen during S, G2, and M phases of the cell cycle, but not during the G0 phase |
Expression | Increases late in the G1 phase, reaches its maximum in the S phase, and then declines | Expression does not change significantly throughout the cell cycle |
Immunohistochemistry | Used to evaluate cell proliferation in tumors | Used to evaluate cell proliferation in tumors |
Specificity | Considered to be more specific than Ki67 in some studies | Shown to be more sensitive and specific in various tumors analyzed compared to PCNA |
Positive Expression Rate | Higher in cancer tissues than in cancer-adjacent normal tissues | Lower in cancer tissues than PCNA |
Both PCNA and Ki67 are used to evaluate cell proliferation in tumors, but they have different functions and levels of specificity. While PCNA is involved in DNA synthesis and repair pathways, Ki67 is involved in cell proliferation and ribosomal RNA transcription. Their expression can be detected through immunohistochemistry.
- Ki67 vs BrdU
- P53 vs P21
- p53 vs TP53
- Immunocytochemistry vs Immunohistochemistry
- NK Cells vs NKT Cells
- Flow Cytometry vs Immunohistochemistry
- Cancer Cell Cycle vs Normal Cell Cycle
- HeLa Cells vs Cancer Cells
- Immunofluorescence vs Immunohistochemistry
- Gene Cloning vs PCR
- NAAT vs PCR
- EGFR vs HER2
- In Situ Hybridization vs Immunohistochemistry
- Colon Cancer vs Prostate Cancer
- c-ANCA vs p-ANCA
- Consensus PCR vs Pan PCR
- Cancer Cells vs Normal Cells
- Protein Kinase A vs Protein Kinase C
- Cell Cycle Specific vs Cell Cycle Nonspecific